Oppenheimer & Co’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Oppenheimer & Co’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,983	Closed	-$418K	–	1434
2020 Q3	$418K	Sell	2,983 -84,620	-97%	-$10.3M	0.01%	874
2020 Q2	$6.59M	Buy	87,603 +69,323	+379%	+$3.63M	0.17%	121
2020 Q1	$522K	Buy	+18,280	New	+$473K	0.02%	715

Oppenheimer & Co's LVGO Position: Q4 2020 in Review

Oppenheimer & Co sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 2,983 shares — an estimated $418K sold.

Oppenheimer & Co first reported a position in LVGO in Q1 2020 and held it in 3 quarters. The position peaked at $6.59M in Q2 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Oppenheimer & Co reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Oppenheimer & Co sold 2,983 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $418K.
Oppenheimer & Co first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
Oppenheimer & Co's Livongo Health, Inc. Common Stock position peaked at $6.59M in Q2 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.